According to the new market research report, "Cardiovascular Ultrasound System Market by Test Type (Transesophageal, Stress, Transthoracic, Fetal), Technology (2D, 3D & 4D, Doppler Imaging), Device Display (Black & White, Color), End User (Hospitals, Home Care, Ambulatory) - Forecast to 2021", provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the cardiovascular ultrasound market along with the estimates and forecasts of the revenue.

Browse and in-depth TOC on "Cardiovascular Ultrasound System Market”
93– Tables
43 – Figures
164 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=50389652

Growth Boosting Factors:

Increasing incidence of cardiovascular diseases, technological advancements, and advantages of echocardiography over invasive cardiac diagnostic procedures are the major drivers for the cardiovascular ultrasound system market. However, insufficient reimbursement scenario and economic impact of adopting new technologies are restraining the growth of the market.

Global Leaders:

Key players in the cardiovascular ultrasound system market include GE Healthcare (U.S.), Philips Healthcare (The Netherlands), Siemens Healthcare (Germany), Hitachi Medical Corporation (Japan), and Toshiba Medical Systems Corporation (U.S.).

GE Healthcare (U.S.) held the largest share of the cardiovascular ultrasound system market. Over the past three years, the company adopted the strategies of expansions, acquisitions, product launches, and approvals to maintain its position in the cardiovascular ultrasound system market. In August 2016, GE Healthcare launched a new generation of high-end portable compact cardiovascular ultrasound, the Vivid iq at the European Society of Cardiology Congress in Rome (Italy).

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=50389652

Esaote S.p.A, a global cardiac ultrasound products company, offers a broad range of echocardiographs. In order to maintain its position in the cardiovascular ultrasound system market, the company primarily adopts the strategy of product launches. In March 2016, the company launched the MyLab Eight ultrasound system at the European Congress of Radiology and in January 2016, the MyLa Six CrystaLine ultrasound system at the Arab Health 2016. The company enhanced its product portfolio with the launch of these products.

The cardiovascular ultrasound system market is in different phases of growth in different regions. In the U.S. and Europe, this market is in a mature phase with several key players opting to improve the filtration process with advantages such as non-invasiveness, accessibility, bedside evaluation, repeatability, real-time results, good image resolution, and more accurate quantification.

Key players in the market are majorly focusing on product launches and approvals to strengthen their position the market. In June 2016, FUJIFILM Medical Systems U.S.A. Inc., showcased the next generation of its Synapse Cardiovascular, a cardiac imaging tool and SonoSite iViZ, the latest portable ultrasound. Similarly, in November 2015, Siemens Healthcare (Germany) launched its new ultrasound imaging system, the HELX with Touch Control in its Healthcare Acuson S Family.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=50389652

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: [email protected]
Content Source: https://www.marketsandmarkets.com/PressReleases/cardiovascular-ultrasound-system.asp
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cardiovascular-ultrasound-system-market.asp